Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation.

Simple Summary: Acute graft-versus-host disease (aGvHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT), occurring to some degree in over 50% of patients and being a direct cause of death in about 20% of patients. This complication occ...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 16; no. 7; pp. 1357 - 1370
Autores principales: Rowley, Scott D., Gunning, Thomas S., Pelliccia, Michael, Della Pia, Alexandra, Lee, Albert, Behrmann, James, Bangolo, Ayrton, Jandir, Parul, Zhang, Hong, Kaur, Sukhdeep, Suh, Hyung C., Donato, Michele, Albitar, Maher, Ip, Andrew
Formato: research tables/charts Journal Article
Publicado: MDPI Apr2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=176598002&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 176598002
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: Apr2024
      vid: 16
      iid: 7
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        176598002
        176598002
        176598002
        10.3390/cancers16071357
        176598002
      ppf: 1357
      ppct: 13
      formats:
      tig:
        atl: Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation.
      aug:
        au:
          Rowley, Scott D.
          Gunning, Thomas S.
          Pelliccia, Michael
          Della Pia, Alexandra
          Lee, Albert
          Behrmann, James
          Bangolo, Ayrton
          Jandir, Parul
          Zhang, Hong
          Kaur, Sukhdeep
          Suh, Hyung C.
          Donato, Michele
          Albitar, Maher
          Ip, Andrew
        affil: Georgetown University School of Medicine, Washington, DC 20007, USA
      sug:
        subj:
          Machine Learning
          Hematopoietic Stem Cell Transplantation
          Graft Versus Host Disease
          Bone Marrow
          Gene Expression Profiling
          Human
          MicroRNA
          Biological Markers
          Signal Transduction
          Chemokines
          Morbidity
          Remission Induction
          Transferases
          Algorithms
          Overall Survival
      ab: Simple Summary: Acute graft-versus-host disease (aGvHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT), occurring to some degree in over 50% of patients and being a direct cause of death in about 20% of patients. This complication occurs even despite a better understanding of donor selection and GvHD prophylaxis regimens. aGvHD is a complex event in which multiple contributing factors are involved. We performed RNA transcriptome analysis of 1408 genes in bone marrow samples obtained before and after transplantation using machine learning to predict the risk of aGvHD and post-transplant survival for a cohort of patients undergoing HSCT. Differential gene expression identified several signaling pathways in the bone marrow microenvironment that may be major regulators of the complex biology of GvHD, and identified targets of intervention to ameliorate the risk of aGvHD and improve patient survival. Acute graft-versus-host disease (aGvHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). We performed RNA analysis of 1408 candidate genes in bone marrow samples obtained from 167 patients undergoing HSCT. RNA expression data were used in a machine learning algorithm to predict the presence or absence of aGvHD using either random forest or extreme gradient boosting algorithms. Patients were randomly divided into training (2/3 of patients) and validation (1/3 of patients) sets. Using post-HSCT RNA data, the machine learning algorithm selected 92 genes for predicting aGvHD that appear to play a role in PI3/AKT, MAPK, and FOXO signaling, as well as microRNA. The algorithm selected 20 genes for predicting survival included genes involved in MAPK and chemokine signaling. Using pre-HSCT RNA data, the machine learning algorithm selected 400 genes and 700 genes predicting aGvHD and overall survival, but candidate signaling pathways could not be specified in this analysis. These data show that NGS analyses of RNA expression using machine learning algorithms may be useful biomarkers of aGvHD and overall survival for patients undergoing HSCT, allowing for the identification of major signaling pathways associated with HSCT outcomes and helping to dissect the complex steps involved in the development of aGvHD. The analysis of pre-HSCT bone marrow samples may lead to pre-HSCT interventions including choice of remission induction regimens and modifications in patient health before HSCT.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N